Antihistamines in ocular allergy: are they all created equal?
about
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%.A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model.Diagnostics and new developments in the treatment of ocular allergies.Alcaftadine for the prevention of itching associated with allergic conjunctivitis.Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface.Advances in pharmacotherapy for allergic conjunctivitis.
P2860
Antihistamines in ocular allergy: are they all created equal?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antihistamines in ocular allergy: are they all created equal?
@en
Antihistamines in ocular allergy: are they all created equal?
@nl
type
label
Antihistamines in ocular allergy: are they all created equal?
@en
Antihistamines in ocular allergy: are they all created equal?
@nl
prefLabel
Antihistamines in ocular allergy: are they all created equal?
@en
Antihistamines in ocular allergy: are they all created equal?
@nl
P2093
P2860
P1476
Antihistamines in ocular allergy: are they all created equal?
@en
P2093
James T McLaughlin
Mark B Abelson
Paul J Gomes
P2860
P2888
P304
P356
10.1007/S11882-011-0188-5
P577
2011-06-01T00:00:00Z